Immunotherapy Firm’s Triple Combination Trial for Glioblastoma Sees First Patient Dosed
June 27, 2018 at 04:00 AM EDT
Source: Streetwise Reports 06/27/2018 A Maxim Group note discussed the latest clinical endeavor involving a three-pronged approach targeting glioblastoma. In a June 21 research note, Maxim Group analyst Jason McCarthy reported the initiation, with the [...]
